Author

M. G. Pauthner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:ecology & biodiversity· 1 Assay:metagenomics· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. B. Ward· 3 shared B. Nogal· 3 shared C. A. Cottrell· 3 shared D. J. Irvine· 2 shared D. R. Burton· 2 shared G. Ozorowski· 2 shared R. Nedellec· 2 shared R. W. Sanders· 2 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. B. Ward

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Focusing antibody responses to the fusion peptide in rhesusmacaques

C. A. Cottrell, P. P. Pratap, K. M. Cirelli, D. G. Carnathan, C. A. Enemuo, A. Antansijevic, G. Ozorowski, L. M. Sewall, H. Gao, K. M. Greene, J. D. Allen, J. T. Ngo, Y. Choe, B. Nogal, M. Silva, , A. B. Ward

This study uses continuous immunogen delivery in rhesus macaques to focus antibody responses on the HIV fusion peptide, identifying key residues for vaccine design.

bioRxiv · Jun 26, 2023 · PreprintImmunology

Predicting the evolution of Lassa Virus endemic area and population at risk over the next decades

R. Klitting, L. E. Kafetzopoulou, W. Thiery, G. Dudas, S. Gryseels, A. Kotamarthi, B. Vrancken, K. Gangavarapu, M. Momoh, J. Demby Sandy, A. Goba, F. Alhasan, D. S. Grant, R. F. Garry, A. R. Smither, , S. Dellicour

The paper predicts that Lassa virus endemic areas will expand beyond West Africa due to environmental changes, increasing the population at risk from 100 million to 700 million by 2070.

bioRxiv · Sep 22, 2021Microbiology

HIV Envelope Trimer-Elicited Autologous Neutralizing Antibodies Bind a Region Overlapping the N332 Glycan Supersite

B. Nogal, L. E. McCoy, M. J. van Gils, C. A. Cottrell, J. E. Voss, R. Andrabi, M. G. Pauthner, C.-H. Liang, T. Messmer, R. Nedellec, M. Shin, H. L. Turner, G. Ozorowski, R. W. Sanders, D. Burton, A. B. Ward

The paper identifies monoclonal antibodies from rabbits that bind an epitope overlapping the N332 glycan supersite but not the glycan hole, suggesting strain-specific responses may interfere with broadly neutralizing antibodies.

bioRxiv · Nov 5, 2019Immunology

Vaccine-induced protection from homologous Tier 2 simian-human immunodeficiency virus challenge in nonhuman primates

M. G. Pauthner, J. P. Nkolola, C. Havenar-Daughton, B. Murrell, S. M. Reiss, R. Bastidas, J. Prevost, R. Nedellec, B. von Bredow, P. Abbink, C. A. Cottrell, D. W. Kulp, T. Tokatlian, B. Nogal, M. Bianchi, , D. R. Burton

This study shows that high serum neutralizing antibody titers from Env protein vaccination protect rhesus macaques from Tier 2 SHIV challenge, with ~1:500 ID50 titers providing over 90% protection.

bioRxiv · Oct 29, 2018Immunology